Aims To investigate the antimicrobial activity of various natural products against Clostridium
difficile in vitro. Methods and Results The antibacterial activity of 20 natural products was …

Aims To investigate the mechanisms of action of natural products with bactericidal
(cinnamon root powder, peppermint oil, trans‐cinnamaldehyde, menthol and zingerone) or …

Objectives Clostridium difficile is a causative agent of nosocomial diarrhoea worldwide
including KSA. Antibiotic treatment of C. difficile infections has been associated with …

The detection of resistant strains of Clostridioides difficile against existing antibiotics and the
side effects led to the investigation of alternative agents. Inhibition zones of various essential …

Aims There is a need for novel treatments for Clostridium difficile infection (CDI).
Antibacterial flavonoids are part of a large family of polyphenol phytochemicals with a long …

Clostridium difficile is an anaerobic, Gram-positive, spore-forming bacillus that causes
disease ranging from self-limiting diarrhoea to severe pseudomembranous colitis. C. difficile …

Clostridium difficile infection is a toxin-mediated disease of the colon. C. difficile virulence is
primarily attributed to the production of toxin A and toxin B; thus this study was aimed to …

Clostridium difficile infection (CDI) has become a significant threat to public health. Although
broad-spectrum antibiotic therapy is the primary treatment option for CDI., its use has evident …

Clostridium difficile infection is a serious condition responsible for significant morbidity and
mortality, especially in patients being treated with antimicrobials. Increasing frequency of the …

Purpose. Clostridium difficile is an anaerobic spore-forming pathogen that causes a serious
toxin-mediated enteric disease in humans. Therapeutic agents that are capable of reducing …